Discover how conscious sedation is transforming gynecologic care by making essential procedures—like pap smears, IUD ...

About 6% of children who were sedated with combinations of ketamine, morphine, and midazolam experienced adverse events, all of which were minor, except for one case of respiratory failure. Several ...

Byfavo, a Schedule IV controlled substance, is a rapid-acting, reversible benzodiazepine. Byfavo ™ (remimazolam; Acacia Pharma) is now available for the induction and maintenance of procedural ...

Findings showed MELT-300 was statistically superior to both sublingual midazolam and placebo for providing successful procedural sedation. Topline results were announced from a phase 3 trial ...

BACKGROUND: Children with Attention Deficit Hyperactivity Disorder (ADHD) have a higher rate of more severe injuries than the general population. However, it is unclear if their ADHD causes them to ...

Please provide your email address to receive an email when new articles are posted on . Conscious sedation was not superior to general anesthesia for functional recovery in patients undergoing ...

Objectives: Although generally effective for sedation during noninvasive procedures, dexmedetomidine as the sole agent has not been uniformly successful for invasive procedures. To overcome some of ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the, Inc. (Melt), a clinical-stage pharmaceutical company ...

Harrow Health ( ($HROW) ) has provided an announcement. On November 17, 2025, Harrow, Inc. completed its acquisition of Melt Pharmaceuticals, ...

Harrow has completed its deal to acquire Melt Pharmaceuticals, according to a company press release. Harrow announced its plan to acquire Melt in September and said it planned to submit a new drug ...